My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 363

    1.

    Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control.

    Bonora E, Calcaterra F, Lombardi S, Bonfante N, Formentini G, Bonadonna RC, Muggeo M.

    Diabetes Care. 2001 Dec;24(12):2023-9.PMID: 11723077 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Contribution of fasting and postprandial hyperglycemia to hemoglobin A1c in insulin-treated Japanese diabetic patients.

    Shimizu H, Uehara Y, Okada S, Mori M.

    Endocr J. 2008 Aug;55(4):753-6. Epub 2008 May 23.PMID: 18497454 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Strongest correlation of HbA(1c) with 1-month-earlier glucose levels in type 2 diabetes.

    Nakazaki M, Fukushige E, Koriyama N, Fukudome M, Hashiguchi H, Aso K, Yano J, Ikeda Y, Kato K, Tei C.

    Diabetes Res Clin Pract. 2004 Mar;63(3):171-7.PMID: 14757288 [PubMed - indexed for MEDLINE]Related articles

    4.

    Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.

    Rossetti P, Pampanelli S, Fanelli C, Porcellati F, Costa E, Torlone E, Scionti L, Bolli GB.

    Diabetes Care. 2003 May;26(5):1490-6.PMID: 12716810 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    6.

    Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.

    Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A.

    Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.PMID: 17919531 [PubMed - indexed for MEDLINE]Related articles

    7.

    What is the relative contribution of blood glucose levels at different time points of the day to HbA1c in Type 1 diabetes?

    Hillman N, Herranz L, Grande C, Vaquero PM, Pallardo LF.

    Diabet Med. 2004 May;21(5):468-70.PMID: 15089792 [PubMed - indexed for MEDLINE]Related articles

    8.

    Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).

    Murata GH, Shah JH, Hoffman RM, Wendel CS, Adam KD, Solvas PA, Bokhari SU, Duckworth WC; Diabetes Outcomes in Veterans Study (DOVES).

    Diabetes Care. 2003 Jun;26(6):1759-63.PMID: 12766106 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients.

    Salardi S, Zucchini S, Santoni R, Ragni L, Gualandi S, Cicognani A, Cacciari E.

    Diabetes Care. 2002 Oct;25(10):1840-4.PMID: 12351488 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Utility of casual postprandial glucose levels in type 2 diabetes management.

    El-Kebbi IM, Ziemer DC, Cook CB, Gallina DL, Barnes CS, Phillips LS.

    Diabetes Care. 2004 Feb;27(2):335-9.PMID: 14747210 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients.

    Makris K, Spanou L, Rambaouni-Antoneli A, Koniari K, Drakopoulos I, Rizos D, Haliassos A.

    Diabet Med. 2008 Feb;25(2):174-8.PMID: 18290858 [PubMed - indexed for MEDLINE]Related articles

    12.

    Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.

    Jesudason DR, Dunstan K, Leong D, Wittert GA.

    Diabetes Care. 2003 Feb;26(2):485-90.PMID: 12547886 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.

    Harris MI; National Health and Nutrition Examination Survey (NHANES III).

    Diabetes Care. 2001 Jun;24(6):979-82.PMID: 11375356 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available.

    Ozmen S, Cil T, Atay AE, Tuzcu AK, Bahceci M.

    Diabet Med. 2006 Oct;23(10):1151-4.PMID: 16978383 [PubMed - indexed for MEDLINE]Related articles

    15.

    Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.

    Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE.

    Diabetes Care. 2002 Feb;25(2):275-8.PMID: 11815495 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.

    Carroll MF, Izard A, Riboni K, Burge MR, Schade DS.

    Diabetes Care. 2002 Dec;25(12):2147-52.PMID: 12453952 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The application of plasma 1,5-anhydro-D-glucitol for monitoring type 2 diabetic patients.

    Dworacka M, Winiarska H.

    Dis Markers. 2005;21(3):127-32.PMID: 16276006 [PubMed - indexed for MEDLINE]Related articles

    18.

    Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS).

    Schaepelynck-Bélicar P, Vague P, Simonin G, Lassmann-Vague V.

    Diabetes Metab. 2003 Dec;29(6):608-12.PMID: 14707890 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.

    Luis Bautista J, Bugos C, Dirnberger G, Atherton T.

    Clin Ther. 2003 Jan;25(1):194-209.PMID: 12637120 [PubMed - indexed for MEDLINE]Related articles

    20.

    Efficacy of Ipomoea batatas (Caiapo) on diabetes control in type 2 diabetic subjects treated with diet.

    Ludvik B, Neuffer B, Pacini G.

    Diabetes Care. 2004 Feb;27(2):436-40.PMID: 14747225 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is temporarily unavailable.

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...